Fig. 1From: Role of DNA repair defects in predicting immunotherapy responseDNA damage response regulates tumor immunity. Defects in DNA damage response can result in both immunostimulation and immunosuppression. Production of neoantigens and/or activation of the cGAS/STING pathway can initiate anti-tumor immunityBack to article page